Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.24
+1.30 (2.89%)
Mar 25, 2026, 11:16 AM EDT - Market open
Kiniksa Pharmaceuticals International, (KNSA) Revenue by Segment
History
| Date | Product | License and Collaboration |
|---|---|---|
| Dec 31, 2025 | 677.56M | - |
| Sep 30, 2025 | 597.97M | - |
| Jun 30, 2025 | 529.33M | - |
| Mar 31, 2025 | 475.93M | - |
| Dec 31, 2024 | 417.03M | - |
| Sep 30, 2024 | 365.71M | - |
| Jun 30, 2024 | 318.30M | 20.63M |
| Mar 31, 2024 | 269.40M | 32.37M |
| Dec 31, 2023 | 233.18M | 37.08M |
| Sep 30, 2023 | 201.90M | 46.85M |
| Jun 30, 2023 | 170.52M | 110.32M |
| Mar 31, 2023 | 142.99M | 93.34M |
| Dec 31, 2022 | 122.52M | 97.66M |
| Sep 30, 2022 | 101.33M | 75.71M |
| Jun 30, 2022 | 80.00M | - |
| Mar 31, 2022 | 60.73M | 10.00M |
| Dec 31, 2021 | 38.54M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.